Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials.
Standard
Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials. / Wieser, Martina; Sauerland, Stefan; Arnold, Dirk; Schmiegel, Wolff; Reinacher-Schick, Anke.
in: BMC CANCER, Jahrgang 10, 2010, S. 309.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials.
AU - Wieser, Martina
AU - Sauerland, Stefan
AU - Arnold, Dirk
AU - Schmiegel, Wolff
AU - Reinacher-Schick, Anke
PY - 2010
Y1 - 2010
N2 - The role of peri-operative chemotherapy in patients with resected stage IV colorectal cancer (CRC) remains to be defined. This study was aimed at evaluating the effectiveness of peri-operative chemotherapy in patients with resected stage IV CRC by performing a meta-analysis of relevant trials.
AB - The role of peri-operative chemotherapy in patients with resected stage IV colorectal cancer (CRC) remains to be defined. This study was aimed at evaluating the effectiveness of peri-operative chemotherapy in patients with resected stage IV CRC by performing a meta-analysis of relevant trials.
KW - Humans
KW - Randomized Controlled Trials as Topic
KW - Treatment Outcome
KW - Meta-Analysis as Topic
KW - Antineoplastic Agents therapeutic use
KW - Liver Neoplasms drug therapy
KW - Colorectal Neoplasms drug therapy
KW - Humans
KW - Randomized Controlled Trials as Topic
KW - Treatment Outcome
KW - Meta-Analysis as Topic
KW - Antineoplastic Agents therapeutic use
KW - Liver Neoplasms drug therapy
KW - Colorectal Neoplasms drug therapy
U2 - 10.1186/1471-2407-10-309
DO - 10.1186/1471-2407-10-309
M3 - SCORING: Zeitschriftenaufsatz
VL - 10
SP - 309
JO - BMC CANCER
JF - BMC CANCER
SN - 1471-2407
ER -